Securities code: Meinian Onehealth Healthcare Holdings Co.Ltd(002044) securities abbreviation: Meinian Onehealth Healthcare Holdings Co.Ltd(002044)
Meinian Onehealth Healthcare Holdings Co.Ltd(002044)
Record of investor relations activities
No.: 202202
Investor relations □ specific object research □ analyst meeting □ media interview
Activity category □ performance presentation □ press conference □ Roadshow
□ site visit √ others (teleconference)
Zhu Hongyu Investment Promotion Fund, Fang Wei Yinhe fund, GUI Yueqiang Taikang fund, Sun Wei Chinese business fund, Xie Jiaoyang Zhonghai fund, LV Huijian Huatai birui fund, Qizhen Huabao fund, Jia Yaxi China Europe Fund, Liu allied alliance Tianhong fund, Li Guangrong yifangda fund, Xiang qiujinghui Tianfu fund, Ren Yilin Guotai fund, Liu Xiyang RONGTONG fund, Xia Linfeng Huabao fund Name of Li Miao fuguoji participants: Jin, Xiao Jing Fuguo fund, Jin yaominjia fund, Chutian Shupu silver fund, Sun Sheng jianxinji and names of personnel
Jin, Liu Zijie Zhonggeng fund, Cao fan South Fund, Chen Jing Taikang asset management, Yu Bo yifangda fund, Peng Weixi Fuguo fund, Zhang xiulei Tianhong fund, Wang Jincheng Huatai assets, Wang Yi Fuguo fund, Wang conghongnian assets, Li Chao huitianfu fund, Cai Mingzi open source securities and Gu Yihan open source securities (31 people in total, regardless of order)
Time: April 30, 2022
Location teleconference
The company received Mr. Yu Rong, chairman of the board; Mr. Xu Tao, director and President; Name of vice president, Ms. Dong Mi Lin Qing
1. Please introduce the market pattern of physical examination market in recent years.
From the overall macro environment, including the demand of clients, after the epidemic in 2020, the whole physical examination market has been steadily improved, and the business volume of public hospitals and other institutions has shown an upward trend in investor relations.
In terms of policy, the third class hospitals prefer to diagnose and treat difficult and severe diseases and key diseases. The introduction of preventive medicine and health management are mainly completed by non-public medical treatment and communities. Under the epidemic situation, the hospital’s reception capacity has decreased to a certain extent, and the price has increased significantly, resulting in a certain overflow of demand, and the company’s undertaking demand has increased.
In terms of competition pattern, public health awareness has been improved under the epidemic, and the demand for health management, physical examination value-added services has increased. The company adheres to the core strategy of “medical oriented, quality driven, service support and innovation leading”, further improves the level of fine management and digitization, improves innovation and product power, and exercises internal skills. Its competitiveness will be gradually released.
2. Under the influence of the current epidemic, what is the overall operating pressure of the company?
From January to February this year, the company continued its growth in the second half of last year, with revenue increasing by 17%, passenger flow increasing by 12%, and customer order increasing by 5%, realizing the simultaneous rise of volume and price. In March, the business in East China and Northeast China was affected by the epidemic, but other regions, including Zhejiang, Hainan, Gansu and Xinjiang, maintained good performance growth, and the company’s revenue and profit in the first quarter were basically the same as that in the first quarter of last year.
Although the number of people who came to the hospital in March was affected by the epidemic, the overall growth of signing orders maintained a good trend. In the next stage, the company will focus on its main business, promote the fine operation of medical quality and services, increase cost reduction and efficiency, and prepare for the resumption of work and production. Focus on the development of high-quality customers of government and enterprises, promote individual inspection marketing and promote inspection at the same time. Promote stock and innovation projects, including traditional capsule gastroscope, brain health, lung health, immune cell storage and other projects, as well as covid-19 self-test box related businesses. In terms of nucleic acid detection, the company cooperates with various regions in Shanghai and Wuhan to contact fixed-point sampling, and also provides on-site sampling services for group customers through cooperation with three-party institutions. Continue to promote digital transformation. After the information system and time-sharing reservation system are launched, it is expected to improve the overall production capacity and customer reception capacity in peak seasons. The customer management system has covered 27 cities in 9 provinces by the end of March. The bianque physical examination system is expected to be launched in May and will be promoted as planned.
3. The company’s 2021 annual report shows that the customer unit price has increased by 2.6%. The first quarterly report of 2022 shows that the customer unit price has increased by 12% from January to February. May I ask why the customer unit price has increased significantly this year?
The company continues to further promote the re purchase rate, re introduction and customer unit price by improving medical quality and services. The increase of customer unit price in the first quarter of 2022, especially from January to February, is a continuation of the quality driven strategy implemented by the company in 2021. At the same time, it precedes the marketing plan arrangement in the first quarter, focuses on individual inspection, and promotes the marketing activities in the National Thanksgiving season. The proportion of individual inspection has increased by 1% year-on-year. At the same time, the price of basic items of individual check-in door packages and physical examination items has been increased. On the group list, further promote and implement the optimization of product structure and the development of high-quality customers, resulting in the rapid growth of customer unit price. 4. Please introduce the schedule of the company’s physical examination center.
The scheduling is basically monthly, generally one month later.
5. What about the level of customers’ repurchase rate and the target of this year’s repurchase rate?
The overall repurchase rate of the company increased steadily in the first quarter of 2022. With the continuous improvement of refined management and service quality in the past two years, the repurchase rate of customers has increased continuously, and the repurchase rate of high-quality customers in some key cities has reached more than 70%. The repurchase rate of individual inspection is influenced by multiple factors, but it has also improved on the whole. The company aims to achieve a repurchase rate of more than 70% for important high-quality customers of group inspection in 2022.
6. As for the company’s marketing strategy, are there any new plans for the festival Wuxi Online Offline Communication Information Technology Co.Ltd(300959) promotion?
The company’s festival marketing is more inclined to individual inspection and e-commerce, which is divided into four seasons throughout the year. First, in the Thanksgiving season before and after the Spring Festival, in the relatively off-season of physical examination in the first quarter, the national linkage mainly promotes a check card and cooperates with tmall, jd.com, word-of-mouth, etc; In the second quarter, the marketing link focusing on 618 was launched in mid and late May; In the third quarter, during the summer vacation, organize individual inspection publicity and arrangement for schools and teachers; In the fourth quarter, make marketing arrangements around the double 11 and double 12.
Different from previous years, this year the company solidified the marketing rhythm of the whole e-commerce individual inspection part and carried out national linkage at the same time. Increase product power in e-commerce Wuxi Online Offline Communication Information Technology Co.Ltd(300959) s, integrate innovative products into e-commerce business, conduct in-depth cooperation with meituan in the local area, and broadcast talent in Tiktok.
7. How is the information system going online?
In 2021, the company carried out the whole digital planning, including the construction of customer dual end applet, app, b-end customer management system, order reservation applet, bianque physical examination system, data center, etc. from the front end, the overall promotion is within the plan. It is planned to promote the national coverage of b-end customer management system in 2022; The bianque physical examination system was launched in mid May to increase the coverage of holding stores before September 30; The data center includes commodity flow, order flow and cash flow to realize closed-loop management. At the same time, the company will continue to promote human efficiency, flat efficiency and 10000 yuan human output. Under the refined management of the business end, the sales human efficiency and store average flat efficiency are expected to be released gradually. After the digital system runs through, it is expected that the changes will be more obvious in the second half of 2022 and 2023.
8. Is there room for capacity improvement in the second half of 2022?
In the peak season of the second half of the year, on the premise of ensuring medical quality and service, through digital operation, time-sharing appointment is adopted to further release production capacity, including locking high-quality customer orders in advance; Increase the development of afternoon business, and improve the afternoon program for the single inspection and re inspection of some indicators that are less sensitive to fasting
Line leading.
9. Internal and external conditions, future expansion mode?
With the gradual maturity of the company’s team and business environment in various cities, the company will orderly merge and acquire the in vitro high-quality physical examination center in the next three years to continuously optimize the store structure.
There are three main driving factors for the company’s sustainable growth in the future: first, endogenous growth through the release of production capacity, human efficiency and floor efficiency; Second, the driving force of the company’s innovative product power to growth; The third is to control the growth of in vitro stores. The company has a clear plan for participation and change control, which is considered from two perspectives: first, the whole business end of the store, including medical quality, service and customer repurchase rate; Second, the overall profitability and growth in the past few years, including the performance forecast in the next three years and the help to the company’s overall market share.
Annex list none (if any)
Date: April 30, 2022
